52

ChikunBlock Product Presentation - 2015

Embed Size (px)

Citation preview

CHIKUNBLOCK PRESENTATIONIn this presentation we want to present to you and create awareness

about Mosquito related diseases and how you can reduce the risk of

mosquito bite with a new, natural and patented Mosquito Repellent.

CHIKUNBLOCK - The Natural Mosquito Repellant, a thee in one

product that combines Repellant, Sun Block and Skin Moisturizer

CHIKUNBLOCK has been created in Puerto Rico / USA, that, at the

time, is suffering an epidemic of the Chungunya Mosquito and that is

rapidly spreading Chikungunya fever throughout the country.

CHIKUNBLOCK PRESENTATIONWe also want to create awareness to the business opportunity related

with this unique CHIKUNBLOCK product. .

CHIKUNBLOCK is now being offered by Global Project Funding AG

(department FIBD Business) to international Importers, Distributors

and Whole Sellers for exclusive distribution. If you are in the Skin Care,

Insect Repellent Business are Travel Business this could be a very

interesting new product for you portfolio.

Many countries suffer from the bites from these little beasts, called

Mosquito. CHIKUNBLOCK an Interesting Business Opportunity!

Let’s stop the new virus!

Chikungunya is a virus

transmitted by a mosquito bite

MOSQUITO BORN ILLNESSES INCLUDE:

• Malaria

• Dengue

• West Nile Virus

• Chikungunya

• Yellow Fever

• Japanese Encephalitis

• St Louis Encephalitis

• Western Equine Encephalitis

• Venezuelan Equine Encephalitis

• Eastern Equine Encephalitis

• La Crosse Virus

INSECTICIDE & INSECT REPELLANT

Our planet is not only covered in insecticides, pesticides and other

toxic chemicals, but these detrimental substances are in the air, soil,

our bodies and water supplies; 97% in America contain DEET!

Each year over 200,000 people die from pesticide poisoning. DEET

is the only pesticide allowed to be put directly on people's skin!!

It is hardly surprising that cancer rates are rising with all of this

chemical bombardment on our bodies and the environment around

us. Yes, bugs & mosquitos can be bad, especially when carrying

deadly diseases but there is no need for this chemical overkill when

there is a natural, safer alternative….

THE IDEAL PRODUCT WOULD HAVE:

o Natural Insect Repellent Properties

Yykkss,thisstuff is natural!OMG! I got to

get away fromhere!

o Sunblock Properties

Skin

Su

n B

loc

k

THE IDEAL PRODUCT WOULD HAVE:

o Skin Moisturizing Properties

THE IDEAL PRODUCT WOULD HAVE:

The Solution:

CHIKUNBLOCK

o Natural Insect Repellent

o Sunblock / SPF30

o Moisturizing Lotion

ALL IN ONE!

First Product:

CHIKUNBLOCK

First Product:

CHIKUNBLOCK Label

CHIKUNBLOCK is made in

Salinas, Puerto Rico / USA

CHIKUNBLOCK Patent

Number…

o Mosquito Repellent Patent No.

o US 8,691,299 B2

UNIQUE SELLING POINT &CONSUMER INTEREST

• 100% Natural Mosquito Repellent Formulation, Eco-friendly, no

harmful effects of chemicals.

• Excellent for caring adults & children

• 4 to 6 Hours Protection

• Prevents mosquito bites from infectious diseases such as; Dengue,

Malaria, West Nile Virus and nowadays the Chikungunya Virus.

UNIQUE SELLING POINT &CONSUMER INTEREST

• No smells, no oils, no tradeoffs.

• Application is easy, no mess.

• An added benefit of a Sun Protector Factor (SPF30)

• And also an added benefit of a cream moisturizing lotion with a

delicate scent.

UNIQUE SELLING POINT &CONSUMER INTEREST

No smells, no oils, no tradeoffs, Application is easy, no mess, An

added benefit of a Sun Protector Factor (SPF30), And also an

added benefit of a cream moisturizing lotion with a delicate scent.

UNIQUE COMPOSITION

Contains Natural substances like:

• Jojoba

• Aloe Vera

• Argan Oil

• Lemon extract

• Peppermint extract

• Vitamins C, B1, B2, B6, B12

EASY TO USETo achive best results:

• Spread evenly and consistantly over all over all

exposed skin.

• Apply to hand for application and rub on

• The product schold not be applied to eyes & mouth

• Should be reapplied every 4 to 6 hours

• Reapplication also after swimming, perspiration,

vigorous activity or toweling

• Caution for people allergic to sunblock products

CHALLENGES

• Requires a considerate investment in marketing and

promotion for market introduction.

• New brand

• New product

The development of new products such as:

• CHIKUNBLOCK SPRAY

• CHIKUNBLOCK 100% Natural Juices

• CHIKUNBLOCK Water

• CHIKUNBLOCK Add On – An envelope like equal that could be added

to any drink.

• CHIKUNBLOCK - Mosquito Repellent Natural Pill.

• CHIKUNBLOCK Syrup

CHALLENGES

CHICUGUNYA VIRUS

• Chikungunya (pronunciation: \chik-en-gun-ye) virus is transmitted to

people by mosquitoes.

• The most common symptoms of Chikungunya virus infection are fever

and joint pain. Other symptoms may include headache, muscle

pain, joint swelling, or rash.

• Outbreaks have occurred in countries in Africa, Asia, Europe, and

the Indian & Pacific Oceans. In late 2013, Chikungunya virus was

found for the first time in the Americas on islands in the Caribbean.

CHICUGUNYA VIRUS

• There is a risk that the virus will be imported to new areas by infected

travelers. There is no vaccine to prevent or medicine to treat

Chikungunya virus infection. Travelers can protect themselves by

preventing mosquito bites.

• When traveling to countries with Chikungunya virus, use insect

repellent, wear long sleeves & pants and stay in places with air

conditioning or that use window & door screens.

CHICUGUNYA VIRUS

Prevention

• No vaccine exists to prevent Chikungunya virus infection or disease.

• Prevent Chikungunya virus infection by avoiding mosquito bites

(see below).

• The mosquitoes that spread the Chikungunya virus bite mostly

during the daytime.

SAN JUAN, Puerto Rico (AP) -- Health officials in Puerto Rico on

Thursday declared an epidemic of the mosquito-borne virus known

as Chikungunya, which was introduced into the Caribbean region

late last year.

Health Secretary Ana Rius said that more than 200 cases had

been confirmed on the island as of June 25 and that the majority of

them were reported in the capital of San Juan and nearby areas.

The first case of Chikungunya in the U.S. territory was reported in late May 2014.

PUERTO RICO DECLARES

CHIKUNGUNYA EPIDEMIC

Also on Thursday, officials in Jamaica reported the island's first

confirmed case. The chief medical officer, Dr. Kevin Harvey, said

the virus was found in a person who had recently traveled to a

country where there have been locally transmitted cases.

In Florida, health officials reported the first domestically acquired

Chikungunya infections in the United States. Officials said it

happened in two cases, both of which involved a person infected

with the virus after visiting the Caribbean being bitten again by an

uninfected mosquito in Florida, which then transmitted the illness further.

PUERTO RICO DECLARES

CHIKUNGUNYA EPIDEMIC

Across the Caribbean, the Pan American Health Organization

recorded more than 354,000 suspected and confirmed cases as of

July 11. The Western Hemisphere's first locally transmitted case

was confirmed in December in the French Caribbean territory of St.

Martin.

Chikungunya was first identified in Africa in 1953. It causes a high

fever and severe pain in the joints, but is rarely fatal. There is no

vaccine, and it mainly is treated with pain medication.

PUERTO RICO DECLARES

CHIKUNGUNYA EPIDEMIC

• Dengue virus has become a serious public health hazard in Puerto

Rico, with many cases reported each year.

• In 2007, 11,000 cases were reported (and many more uncalled for)

with 8 of those ending in death!

• Because there is no vaccine, Public Health Officials in Puerto Rico

considered alternative methods like massive fumigation and public

education that includes how to recognize symptoms of Dengue Fever

and how to keep areas clean of standing water.

DENGUE IN PUERTO RICO

• Around 500 million people (more than 40% of the world

population) is at risk of contracting the Dengue Fever.

• Before 1970, nine countries in the world had suffered an

epidemic from the most severe type of virus, hemorrhagic

dengue.

• In 2010 1.6 million cases were reported in North and

South America only and 49,000 of those cases were

hemorrhagic Dengue

• In 2010 2.3 million cases were reported in total.

• Not only is the incidence of cases are increasing, but as

the virus expands to new areas and new outbreaks of the

virus are rapidly becoming life-threatening epidemics.

DENGUE AROUND THE WORLD

Treatment

• There is no specific treatment for

Dengue Fever.

• In the case of Hemorrhagic Dengue

Fever, medical assistance by

experienced doctors and nurses

familiar with evolution of the disease

may represent the difference between

life and death and may reduce

mortality rate from 20% to 1%.

• It is imperative to maintain the intake

of fluids. Dehydration is eminent.

Immunization

• There is no vaccine to protect us

against Dengue Fever.

• It has been very difficult to develop a

vaccine against the Dengue Fever, but

in recent years improvements have

been made.

• Various vaccines are in trial and

developmental phases.

DENGUE TREATMENT & IMMUNIZATION

• Malaria Is a mosquito-borne zoonotic arbovirus.

• This is found in temperate and tropical regions of the world.

• It was first identified in the West Nile sub region in the east African

region of Uganda in 1937.

• The main mode of WNV transmission is via various species of

mosquitoes, which are the prime vector, with birds being the most

commonly infected animal and serving as the prime reservoir host –

specially passerines, which are of largest birds.

WEST NILE VIRUS

• WNV also affects various mammal species, including humans, and

has been identified on reptilian species, including alligators and

crocodiles.

• Approximately 80% of the WNV infections in humans are

subclinical, which cause no symptoms.

• In the case where symptoms do occur the time from infection to the

appearance of symptoms is typically between 2 and 15

days. Symptoms may include fever, headaches, fatigue, muscle pain

or aches, malaise, nausea, anorexia, vomiting, myalgias and rash.

• Currently, no vaccine against WNV infection is available.

WEST NILE VIRUS

39%61%

REPELLENT SALES VS POPULATION IN USA

Sales $200,000,000.00

Population 313,232,044

COMPETITION

• OFF!

• Real Kill

• Cutter

• Repel

• Raid

• Skinstastic

CONCLUSSIONNo doubt we have render you with a breakthrough, this product

surpasses Off, Raid, and Cutter in benefits, effectiveness, and aroma.

With an effective Marketing Plan, our product will provide your

consumer’s with a healthy product that protects not only the skin,

and from sun rays, but also from a potentially deadly enemy that

nurses in our backyards!

Lets protect our Families & Children!

Don’t let the bugs and sun spoil your fun!

BEAT THEM UP WITH

CHIKUNBLOCK!

PRIVATE LABLE

If you like to sell Chikunblock under your own Band Name we are ready

to Private Label the product for you.

Conditions:

Min. order volume: 10’000pcs

Available sizes (existing packaging): 4oz / 118ml Bottles

Production lead time: 4-6weeks after delivery of design

Payment terms: in advance

CONTACT DETAILS

Global project Funding AG

Department FIBD Business

Samstagernstrasse 45

CH-8832 Wollerau

Switzerland

Tel: +41 (0)79 415 12 15

Web: www.fibdbusiness.com/chikunblock

Email : [email protected]